GILD · NASDAQ · Drug Manufacturers - General

Gilead Sciences

Develops HIV antivirals, liver-disease medicines, and oncology therapies including CAR-T treatments.

$139.30
After-hours close−6.35 (−4.36%)
At close$145.65(−2.16%)

Breakdown13F · Form 4

Institutions 109.50%Insiders 0.09%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 1.24B · Float 1.24B · 99.8% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.121.84M9.81%13FAug 7, 2026
Vanguard Capital Management LLC81.09M6.53%13FAug 13, 2026
FMR LLC66.87M5.39%13FAug 13, 2026
State Street Corp61.22M4.93%13FAug 7, 2026
Capital World Investors40.99M3.30%13FAug 12, 2026

Institutions13F, as of Jun 30, 2026

2,357 holders · 1.36B shares · 158 new positions · 1,106 increased · 856 reduced · 201 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.121.84M9.81%+2.83MAug 7, 2026
Vanguard Capital Management LLC81.09M6.53%+437.0KAug 13, 2026
FMR LLC66.87M5.39%−5.04MAug 13, 2026
State Street Corp61.22M4.93%+1.36MAug 7, 2026
Capital World Investors40.99M3.30%−295.0KAug 12, 2026
Invesco Ltd.39.82M3.21%+13.76MAug 14, 2026
Vanguard Portfolio Management LLC35.32M2.84%+186.7KAug 13, 2026
Geode Capital Management, LLC30.07M2.42%+339.6KAug 12, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
BlackRock, Inc.8.20%101.74M13GApr 24, 2025
Vanguard Capital Management7.51%93.33M13GApr 29, 2026
FMR LLC5.30%65.54M13GFeb 5, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Daniel Patrick O'Daydirector, officer: Chairman & CEO592.1K0.05%Aug 4, 2026
Andrew D. Dickinsonofficer: Chief Financial Officer165.6K0.01%Aug 18, 2026
Johanna Mercierofficer: Chief Comm & Corp Aff Officer118.2K0.01%Aug 18, 2026
Diane E. Wilfongofficer: Interim Corp Controller & CAO46.3K0.00%Sep 11, 2025
Deborah H. Telmanofficer: EVP, Corporate Affairs & GC43.7K0.00%Nov 13, 2025
Sandra Pattersonofficer: SVP, Controllership39.5K0.00%Mar 12, 2025
Jacqueline K. Bartondirector27.2K0.00%May 4, 2026
Dietmar Bergerofficer: Chief Medical Officer19.3K0.00%Jun 11, 2026
Harish Manwanidirector15.0K0.00%May 4, 2026
Javier Rodriguezdirector13.4K0.00%May 4, 2026

28 people have not refiled in the last 18 months (9.08M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 26, 2026
Anthony Weltersdirector
Sale · 4 lots18,000$148.6212,894
Aug 20, 2026
Jeffrey Bluestonedirector
Sale · 5 lots5,000$145.0210,066
Aug 17, 2026
Andrew D. Dickinsonofficer: Chief Financial Officer
Sale3,000$138.36165,646
Aug 17, 2026
Johanna Mercierofficer: Chief Comm & Corp Aff Officer
Sale · 2 lots28,000$137.64118,234
Aug 3, 2026
Daniel Patrick O'Daydirector, officer: Chairman & CEO
Sale · 3 lots15,000$130.31592,133
Jul 15, 2026
Johanna Mercierofficer: Chief Comm & Corp Aff Officer
Sale3,000$129.92121,234
Jul 15, 2026
Andrew D. Dickinsonofficer: Chief Financial Officer
Sale3,000$129.93168,646
Jul 1, 2026
Daniel Patrick O'Daydirector, officer: Chairman & CEO
Sale · 2 lots15,000$126.29607,133
Jun 15, 2026
Andrew D. Dickinsonofficer: Chief Financial Officer
Sale3,000$125.40171,646
Jun 15, 2026
Johanna Mercierofficer: Chief Comm & Corp Aff Officer
Sale · 3 lots3,000$123.92124,234

CongressHouse and Senate disclosures

MemberTypeAmountOwnerTradedDisclosed
Rep. Ro Khanna · CA17Sale$1,001 – $15,000Jul 7, 2026Aug 12, 2026
Sen. Tommy Tuberville · ALPurchase$1,001 – $15,000JointMay 10, 2024Aug 5, 2026
Sen. Tommy Tuberville · ALPurchase$1,001 – $15,000JointMay 10, 2024Aug 5, 2026
Sen. Tommy Tuberville · ALPurchase$1,001 – $15,000JointMay 10, 2024Aug 5, 2026
Rep. Jared Moskowitz · FL23Purchase$1,001 – $15,000May 6, 2026Jun 22, 2026